A double-course compound cell growth factor hydrogel and its preparation method and application
A growth factor and hydrogel technology, which is applied in the direction of drug combinations, pharmaceutical formulas, medical preparations containing active ingredients, etc., can solve the problems of optimization and long skin repair time, and achieve easy absorption, safety and quick effect, no Toxic effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
10mmol / L pH6.8 sterile phosphate buffer
Make up to 1000ml
[0037] No. 1 hydrogel preparation method: 1. 1.0% by mass of organic vegetable glycerin, 0.05% by mass of hyaluronic acid, 3.0% by mass of mannitol, 1.0% by mass of menthol, and 0.2% by mass of decylmethylsulfoxide %, poloxamer 407 mass percentage 20%, swelling and stirring with 10mmol / L pH6.8 sterile phosphate buffer at 4°C, then autoclaving at 121°C for 20 minutes, and cooling;
[0038] 2. Dissolve human fibroblast growth factor hFGF-21 5000IU / g, human epidermal growth factor hEGF40000IU / g, and allantoin mass percentage 2.0% in 10mmol / L pH6.8 sterile phosphate buffer, and use 0.22 um membrane filter sterilization;
[0039] 3. Under aseptic conditions, when the hydrogel obtained in step 1 is cooled to 4°C, mix the solution obtained in step 2 with it and stir evenly, and dispense it into a hose sterilized by ethylene oxide.
[0040] No. 2 hydrogel component
Dosage (mass percentage%)
H...
Embodiment 2
Make up to 1000ml
[0047] No. 1 hydrogel preparation method: 1. 3.0% by mass of organic vegetable glycerin, 0.05% by mass of hyaluronic acid, 1.0% by mass of mannitol, 2.0% by mass of menthol, and 0.1% by mass of decylmethylsulfoxide %, poloxamer 407 mass percentage 20%, swollen and stirred with 10mmol / L pH6.8 sterile buffer solution at 4°C, then autoclaved at 121°C for 20 minutes, and cooled;
[0048] 2. Human fibroblast growth factor hFGF-21 10000IU / g, human epidermal growth factor hEGF20000IU / g, allantoin mass percentage 2.0% were dissolved in a sterile buffer, and sterilized by filtration with a 0.22um filter membrane;
[0049] 3. Under aseptic conditions, when the hydrogel obtained in step 1 is cooled to 4°C, mix the solution obtained in step 2 with it and stir evenly, and dispense it into a hose sterilized by ethylene oxide.
[0050] No. 2 hydrogel component
Dosage (mass percentage%)
Human Keratinocyte Growth Factor hKGF-2
10000IU / g
...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com